BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON
Oct 20, 2023
Big Pharma Giant Kicks Off Q3 Earnings After Hiking Prices More Than 40 Times… Read More
© 2026 CSRXP- All Rights Reserved
Blog Posts
BIG PHARMA WATCH: PFIZER TO RAISE PRICE ON COVID-19 TREATMENT NEARLY 300 PERCENT
Oct 19, 2023
Big Pharma Giant Increases Paxlovid Price Weeks After Making Price Hike on… Read More
BIG PHARMA WATCH: KICKBACKS INCREASED SPENDING ON HIGH PRICED AGE-RELATED MACULAR DEGENERATION DRUGS BY $642.8 MILLION OVER SIX YEARS
Oct 3, 2023
Eye Doctors Who Accepted Big Pharma Payments Were More Likely to Prescribe… Read More
Big Pharma Watch: Study Finds Patent Thickets on Just Four Drugs Extended Monopolies By a Combined 25 Years
Sep 20, 2023
I-MAK Analysis Reveals Patent Abuse on Four Blockbuster Medications Generated… Read More
DOSE OF REALITY: BIG PHARMA’S TWO DECADES OF PRICE HIKES AND ADVERTISING BINGING ON TEN DRUGS ELIGIBLE FOR MEDICARE NEGOTIATION
Sep 20, 2023
A History of Big Pharma’s Egregious Pricing Practices and Billions of… Read More
SECOND OPINION: DEBUNKING BIG PHARMA’S BOGUS INNOVATION RHETORIC
Sep 19, 2023
Brand Name Drug Companies Claim Lowering Rx Prices Will Undercut R&D —… Read More
BIG PHARMA WATCH: LIST PRICES ON TOP 25 MEDICARE PART D DRUGS MORE THAN TRIPLED SINCE COMING TO MARKET
Aug 17, 2023
AARP Analysis Finds Prices for Best-Selling Medicare Part D Drugs Rose 226… Read More
BIG PHARMA EARNINGS WATCH: SANOFI, ASTRAZENECA, AMGEN, ELI LILLY
Aug 14, 2023
Big Pharma Giants Once Again Top Wall Street Expectations in Final Round of… Read More
BIG PHARMA EARNINGS WATCH: PFIZER & MERCK
Aug 7, 2023
More Q2 2023 Earnings Reports Demonstrate Big Pharma Firms Top Wall Street… Read More
BIG PHARMA EARNINGS WATCH: GLAXOSMITHKLINE & ABBVIE
Aug 3, 2023
Big Pharma Giants Boast Better Than Expected Q2 Earnings While Price-Gouging… Read More
BIG PHARMA WATCH: COLOSSAL $81.9 BILLION IN 2022 EARNINGS FOR LARGEST DRUG MAKERS FUELED HUGE PROFITS
Jul 25, 2023
Top Five Drug Makers By U.S. Market Cap Plowed Soaring Earnings Into Stock… Read More
BIG PHARMA WATCH: DRUG MAKER’S PRODUCT-HOPPING SCHEME BLOCKED ACCESS TO SAFER HIV MEDICATIONS TO JUICE PROFITS
Jul 24, 2023
The New York Times Exposes How Gilead Devised Egregious Patent Strategy to… Read More